Table 1.

Effect of EphB4 on primary human CD34+ cells cultured with SCF, TPO, and FL

CD41GlycophrinACD14CD33
VectorEphB4VectorEphB4VectorEphB4VectorEphB4
Sample no.         
4.1 13.8 3.8 11.1 — — — — 
2.9 8.4 2.0 10.5 27.2 40.3 65.4 67.4 
6.8 15.2 2.8 4.6 41.0 33.9 97.4 97.8 
30.2 59.8 18.8 31.7 54.5 44.7 97.2 98.9 
24.4 35.4 10.2 25.2 43.5 44.6 89.5 98.1 
Mean 13.7 26.5 7.5 16.6 41.6 40.9 87.4 90.6 
P .020 .008 .131 .092 
CD41GlycophrinACD14CD33
VectorEphB4VectorEphB4VectorEphB4VectorEphB4
Sample no.         
4.1 13.8 3.8 11.1 — — — — 
2.9 8.4 2.0 10.5 27.2 40.3 65.4 67.4 
6.8 15.2 2.8 4.6 41.0 33.9 97.4 97.8 
30.2 59.8 18.8 31.7 54.5 44.7 97.2 98.9 
24.4 35.4 10.2 25.2 43.5 44.6 89.5 98.1 
Mean 13.7 26.5 7.5 16.6 41.6 40.9 87.4 90.6 
P .020 .008 .131 .092 

CD34+ cells were transduced with MSCV-GFP (vector) or MSCV-EphB4 (EphB4). GFP+ cells were sorted and cultured in the presence of SCF (50 ng/mL), TPO (25 ng/mL), and flt3 ligand (FL) (50 ng/mL) for 7 days. P values were calculated using Wilcoxon matched-pairs signed-rank test.

Close Modal

or Create an Account

Close Modal
Close Modal